These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 17567941)
1. Thymosin alpha1: a historical overview. Garaci E Ann N Y Acad Sci; 2007 Sep; 1112():14-20. PubMed ID: 17567941 [TBL] [Abstract][Full Text] [Related]
2. Historical review of thymosin α 1 in infectious diseases. Camerini R; Garaci E Expert Opin Biol Ther; 2015; 15 Suppl 1():S117-27. PubMed ID: 26098768 [TBL] [Abstract][Full Text] [Related]
3. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2. Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552 [TBL] [Abstract][Full Text] [Related]
4. Thymosin alpha 1: from bench to bedside. Garaci E; Favalli C; Pica F; Sinibaldi Vallebona P; Palamara AT; Matteucci C; Pierimarchi P; Serafino A; Mastino A; Bistoni F; Romani L; Rasi G Ann N Y Acad Sci; 2007 Sep; 1112():225-34. PubMed ID: 17600290 [TBL] [Abstract][Full Text] [Related]
5. Immunopharmacology of thymosin alpha1 and cytokine synergy. Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942 [TBL] [Abstract][Full Text] [Related]
12. Effect of a C-end rule modification on antitumor activity of thymosin α1. Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371 [TBL] [Abstract][Full Text] [Related]
13. Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level. Giuliani C; Napolitano G; Mastino A; Di Vincenzo S; D'Agostini C; Grelli S; Bucci I; Singer DS; Kohn LD; Monaco F; Garaci E; Favalli C Eur J Immunol; 2000 Mar; 30(3):778-86. PubMed ID: 10741392 [TBL] [Abstract][Full Text] [Related]
14. Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes. Yao Q; Doan LX; Zhang R; Bharadwaj U; Li M; Chen C Immunol Lett; 2007 Jun; 110(2):110-20. PubMed ID: 17532057 [TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis of a peptide derivative of thymosin alpha1 and initial studies on its (99m)Tc-radiolabelling. Klimentzou P; Beck A; Varvarigou A; Tsitsilonis O; Voelter W; Pirmettis I; Papadopoulos M; Livaniou E; Zikos C Chem Biol Drug Des; 2007 Jul; 70(1):40-6. PubMed ID: 17630993 [TBL] [Abstract][Full Text] [Related]
17. Thymalfasin: an immune system enhancer for the treatment of liver disease. Sjogren MH J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S69-72. PubMed ID: 15546253 [TBL] [Abstract][Full Text] [Related]
18. The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha. Huang Y; Chen Z; Zhou C; Yao H; Li M; Xu C Int Immunopharmacol; 2004 Apr; 4(4):539-46. PubMed ID: 15099531 [TBL] [Abstract][Full Text] [Related]
19. NMR structural studies of thymosin α1 and β-thymosins. Volk DE; Tuthill CW; Elizondo-Riojas MA; Gorenstein DG Ann N Y Acad Sci; 2012 Oct; 1270():73-8. PubMed ID: 23050820 [TBL] [Abstract][Full Text] [Related]
20. Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy. Naylor PH; Hadden JW Ann N Y Acad Sci; 2010 Apr; 1194():162-8. PubMed ID: 20536465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]